Birlotib 150mg Tablet Description:
Birlotib 150mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Birlotib 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Nausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema (swelling), Weight loss, Loss of appetite, Anemia (low number of red blood cells), Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Birlotib 150mg Tablet is to be taken empty stomach.
Is Birlotib 150mg FDA approved?
Yes, Birlotib 150mg is approved by FDA
How long does Birlotib 150mg work?
A single dose of Birlotib 150mg works for around 36 hours.
Is Birlotib 150mg cytotoxic
Birlotib 150mg is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Birlotib 150mg is a biologic tyrosine kinase inhibitor
Does Birlotib 150mg cause neutropenia?
Yes, Birlotib 150mg can cause neutropenia